BIOMAT Database Logo BIOMAT Database Logo

The effect of fleroxacin and ciprofloxacin on the pharmacokinetics of multiple dose caffeine. 1995

D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Division of Infectious Diseases, Hartford Hospital, CT 06102, USA.

UI MeSH Term Description Entries
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D016037 Single-Blind Method A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned. Single-Masked Study,Single-Blind Study,Single-Masked Method,Method, Single-Blind,Method, Single-Masked,Methods, Single-Blind,Methods, Single-Masked,Single Blind Method,Single Blind Study,Single Masked Method,Single Masked Study,Single-Blind Methods,Single-Blind Studies,Single-Masked Methods,Single-Masked Studies,Studies, Single-Blind,Studies, Single-Masked,Study, Single-Blind,Study, Single-Masked
D016576 Fleroxacin A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE. AM-833,Quinodis,Ro 23-6240,AM 833,AM833,Ro 23 6240,Ro 236240

Related Publications

D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Single and multiple dose pharmacokinetics of fleroxacin.
October 1988, The Journal of antimicrobial chemotherapy,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations.
August 1994, Therapeutic drug monitoring,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers.
January 1995, Drugs,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Single and multiple dose pharmacokinetics of ciprofloxacin.
April 1986, European journal of clinical microbiology,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green.
February 1987, The Journal of antimicrobial chemotherapy,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.
March 1985, Antimicrobial agents and chemotherapy,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
December 1987, Antimicrobial agents and chemotherapy,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
January 1992, Clinical pharmacokinetics,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Multiple dose pharmacokinetics of ciprofloxacin in preterm babies.
October 2004, Indian pediatrics,
D P Nicolau, and C H Nightingale, and P R Tessier, and Q Fu, and D W Xuan, and E M Esguerra, and R Quintiliani
Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
March 1993, The American journal of medicine,
Copied contents to your clipboard!